Guaricci AI, Faggiano A, Wahbi K, Barriales-Villa R, Carella MC, Carugo S, Christensen AH, Forleo C, Gherbesi E, Haugaa KH, Merlo M, Larrañaga-Moreira JM, Mushtaq S, Novelli V, Peretto G, Resta N, Rootwelt-Norberg C, Ben Yaou R, Ciccone MM, Sinagra G, Pontone G(2026) Cardiovascular Prognostic Impact of Missense vs Non-Missense Lamin A/C Variants: A Systematic Review and Meta-Analysis Heart Rhythm(in press) DOI 10.1016/j.hrthm.2025.12.038, PubMed 41500486
Haugaa KH, Hasselberg NE(2025) The cardiac myosin inhibitor era - more than treating left ventricular outflow tract obstruction in hypertrophic cardiomyopathy? Eur Heart J Cardiovasc Imaging(in press) DOI 10.1093/ehjci/jeaf364, PubMed 41422416
Lieve KV, van der Werf C, Kallas D, Denjoy I, Bos JM, Aiba T, Behr ER, van den Berg MP, Bergeman AT, Blom NA, Borggrefe M, Brugada R, Carrillo Mora LM, Chorin E, Crotti L, Davis A, Drago F, Dusi V, Extramiana F, Franciosi S, Giudicessi JR, González Llopis FÁ, Haugaa KH, van den Heuvel F, Horie Met al.(2025) Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification Eur Heart J(in press) DOI 10.1093/eurheartj/ehaf965, PubMed 41416846